Ebert, Natalie
Schneider, Alice
Huscher, Doerte
Mielke, Nina
Balabanova, Yanina
Brobert, Gunnar
Lakenbrink, Carla
Kuhlmann, Martin
Fietz, Anne-Katrin
van der Giet, Markus
Wenning, Volker
Schaeffner, Elke
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 23 February 2023
Accepted: 18 July 2023
First Online: 1 August 2023
Declarations
:
: NE is member of an EAB for Bayer AG Leverkusen. ES has received grants from the National Kidney Foundation for editorial board (AJKD), consulting fees from Astra Zeneca, and honoraria for lectures from Akademie Niere, Berliner Dialyseseminar, Siemens Healthineers and Fresenius Kabi. MvdG has grant contracts from the Berlin Institute of Health and Novartis, received consulting fees from IEM, Pharvaris, Medtronic, Recor and Nephrolyx, honoraria from Bayer, Servier, Omron, Novartis, Boehringer, Recor, Medtrix, Streamedup, and participated in EAD for Novartis. MKK, AS, DH, AKF, NM, CL, YB, GB, and VW declare no competing interests.
: The study was approved by the ethics committee of the Charité University Hospital Berlin, Germany (EA2/009/08). The BIS adheres to the Declaration of Helsinki and rules of “Good Scientific Practice”. All study participants gave written informed consent.
: Not applicable.